OBJECTIVES: To compare the T-cell responses to hepatitis C virus (HCV) and HIV in HIV-infected long-term non-progressors (LT-NP) and HIV-positive progressors co-infected with HCV and in HIV-negative HCV-infected patients. METHODS: Three groups were studied: 10 HCV/HIV-infected LT-NP, 26 HCV/HIV-infected progressors and 13 HCV-infected/HIV-negative patients. Virus-specific CD4 and CD8 T-cell responses in peripheral blood were assessed by interferon (IFN)-gamma Elispot assays using recombinant proteins (HIV-p24 and three HCV antigens) and 16 HIV or HCV HLA A3- and/or HLA A2-restricted cytotoxic T lymphocytes peptides. Statistical analysis was performed with non-parametric tests. RESULTS: In addition to high T helper 1 (Th1) cell frequencies directed against HIV-p24, LT-NP had significantly (P < 0.05) higher frequencies of Th1 cells against HCV than the two other groups. No difference was observed between HIV-infected progressors and HIV-negative controls. Furthermore, HCV-specific CD4 and CD8 T cells were correlated in LT-NP (P = 0.006). CONCLUSION: Thus, independently of the HIV-related immune alterations, LT-NP of the HIV-infection might have an intrinsic capacity to develop strong Th1 cell responses to viruses, particularly HIV and HCV.
OBJECTIVES: To compare the T-cell responses to hepatitis C virus (HCV) and HIV in HIV-infected long-term non-progressors (LT-NP) and HIV-positive progressors co-infected with HCV and in HIV-negative HCV-infectedpatients. METHODS: Three groups were studied: 10 HCV/HIV-infected LT-NP, 26 HCV/HIV-infected progressors and 13 HCV-infected/HIV-negative patients. Virus-specific CD4 and CD8 T-cell responses in peripheral blood were assessed by interferon (IFN)-gamma Elispot assays using recombinant proteins (HIV-p24 and three HCV antigens) and 16 HIV or HCV HLA A3- and/or HLA A2-restricted cytotoxic T lymphocytes peptides. Statistical analysis was performed with non-parametric tests. RESULTS: In addition to high T helper 1 (Th1) cell frequencies directed against HIV-p24, LT-NP had significantly (P < 0.05) higher frequencies of Th1 cells against HCV than the two other groups. No difference was observed between HIV-infected progressors and HIV-negative controls. Furthermore, HCV-specific CD4 and CD8 T cells were correlated in LT-NP (P = 0.006). CONCLUSION: Thus, independently of the HIV-related immune alterations, LT-NP of the HIV-infection might have an intrinsic capacity to develop strong Th1 cell responses to viruses, particularly HIV and HCV.
Authors: Camilla S Graham; Annalee Wells; Tun Liu; Kenneth E Sherman; Marion Peters; Raymond T Chung; Atul K Bhan; Janet Andersen; Margaret James Koziel Journal: AIDS Date: 2006-02-14 Impact factor: 4.177
Authors: Nadia Alatrakchi; Camilla S Graham; Hans J J van der Vliet; Kenneth E Sherman; Mark A Exley; Margaret James Koziel Journal: J Virol Date: 2007-03-21 Impact factor: 5.103
Authors: Camilla S Graham; Annalee Wells; Tun Liu; Kenneth E Sherman; Marion Peters; Raymond T Chung; Atul K Bhan; Janet Andersen; Margaret James Koziel Journal: AIDS Date: 2005-05-20 Impact factor: 4.177
Authors: A Samri; C Durier; A Urrutia; I Sanchez; H Gahery-Segard; S Imbart; M Sinet; E Tartour; J-P Aboulker; B Autran; A Venet Journal: Clin Vaccine Immunol Date: 2006-06
Authors: Stephen Meddows-Taylor; Maria A Papathanasopoulos; Louise Kuhn; Tammy M Meyers; Caroline T Tiemessen Journal: Virus Genes Date: 2004-04 Impact factor: 2.332
Authors: Prasanna Jagannathan; Christine M Osborne; Cassandra Royce; Maura M Manion; John C Tilton; Li Li; Steven Fischer; Claire W Hallahan; Julia A Metcalf; Mary McLaughlin; Matthew Pipeling; John F McDyer; Thomas J Manley; Jeffery L Meier; John D Altman; Laura Hertel; Richard T Davey; Mark Connors; Stephen A Migueles Journal: J Virol Date: 2009-01-07 Impact factor: 5.103